Executive Vice President, Head of Development, and Chief Medical Officer · Sana Biotechnology, Inc. (SANA)

Sunil Agarwal

FY2021 is the first fiscal year CompBrief holds for Sunil Agarwal as a named executive officer of Sana Biotechnology; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2021

$1,928,519

Salary $512,631Stock awards $0Bonus $10,000

1st of 3 named executive officers at Sana Biotechnology by FY2021 total.

3 named officers on file for Sana Biotechnology, FY2021

Sunil Agarwal’s pay file — $29

  • 1 fiscal year of pay, line by line
  • 1 equity grant, each cited to its filing

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Sana Biotechnology’s whole pay program stands against its peers

  • Sana Biotechnology’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on SANA→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 26, 2022 (DEF 14A).

Free

Get Sunil Agarwal’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Sunil Agarwal compensation by year

Sana Biotechnology Summary Compensation Table · the one fiscal year held
In US dollars, as Sana Biotechnology reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2021
Salary$512,631
Bonus$10,000
Stock awards$0
Option awards$1,200,073
Non-equity incentive$205,815
Pension and deferred compensation$0
All other$0
Total$1,928,519

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Sana Biotechnology, Inc. DEF 14A filed April 26, 2022, accession 0001193125-22-118701, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Sana Biotechnology, Inc. filed document, accession 0001193125-22-118701. Every figure is read from that document and cited to the page and table it appears in. Filed April 26, 2022.

Equity holdings

unvested awards at FY2021 year-end
TypeUnvested unitsValue at year-endExercise price
RSU234,792$3,634,580—
Option29,688—$1.44
Option67,709—$1.48
Option76,682—$25.00

Per the Outstanding Equity Awards at Fiscal Year-End table in Sana Biotechnology, Inc.'s FY2021 proxy; value at the fiscal year-end close, as the company printed it.

Sana Biotechnology’s named executive officers, FY2021

as the company reported each
Named executive officerRoleFY2021 total
Sunil Agarwal · this pageExecutive Vice President, Head of Development, and Chief Medical Officer$1,928,519
Steven HarrPresident, Chief Executive Officer, and Director$1,186,154
Nathan HardyExecutive Vice President, Chief Financial Officer$683,493

The full Sana Biotechnology compensation record

free company brief

This page is one person within Sana Biotechnology's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Sana Biotechnology's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Sunil Agarwal's compensation dossier · One-time report. No refunds.